The top documents tagged [hazard ratebased]

Evaluating Change in Hazard in Clinical Trials With Time-to-Event Safety Endpoints Rafia Bhore, PhD Statistical Scientist, Novartis Email: rafia.bhore@novartis.com.

Evaluating Change in Hazard in Clinical Trials With Time-to-Event Safety Endpoints Rafia Bhore, PhD Statistical Scientist, Novartis Email: [email protected].

215 views
Evaluating Change in Hazard in Clinical Trials With Time-to-Event Safety Endpoints

Evaluating Change in Hazard in Clinical Trials With Time-to-Event Safety Endpoints

21 views
Languages
Pages
Legal

Copyright © 2022 FDOCUMENTS